These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 42151

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Biochemical aspects of arrhythmogenesis and ventricular fibrillation.
    Opie LH, Nathan D, Lubbe WF.
    Am J Cardiol; 1979 Jan; 43(1):131-48. PubMed ID: 31786
    [No Abstract] [Full Text] [Related]

  • 3. Calcium antagonists, ventricular fibrillation, and enzyme release in ischemic rat hearts.
    Opie LH, Thandroyen FT.
    Fed Proc; 1983 May 15; 42(8):2465-9. PubMed ID: 6132839
    [Abstract] [Full Text] [Related]

  • 4. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors.
    Lubbe WF, Podzuweit T, Opie LH.
    J Am Coll Cardiol; 1992 Jun 15; 19(7):1622-33. PubMed ID: 1350597
    [Abstract] [Full Text] [Related]

  • 5. Effect of interventions that increase cyclic AMP levels on susceptibility to ventricular fibrillation in unanesthetized dogs.
    Avendano CE, Billman GE.
    Eur J Pharmacol; 1994 Apr 01; 255(1-3):99-109. PubMed ID: 7517886
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Independent contribution of catecholamines to arrhythmogenesis during evolving infarction in the isolated rat heart.
    Clements-Jewery H, Hearse DJ, Curtis MJ.
    Br J Pharmacol; 2002 Feb 01; 135(3):807-15. PubMed ID: 11834629
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-arrhythmic effect of DL-propranolol, D-propranolol and I. C. I. 50 172 in experimental myocardial infarction in the dog.
    Staszewska-Barczak J.
    Acta Physiol Pol; 1970 Feb 01; 21(3):260-70. PubMed ID: 4396953
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
    Gülker H, Thale J, Brisse B, Bender F.
    Z Kardiol; 1984 Aug 01; 73(8):515-24. PubMed ID: 6495811
    [Abstract] [Full Text] [Related]

  • 16. Electrophysiologic effects of beta blockers in ventricular arrhythmias.
    Venditti FJ, Garan H, Ruskin JN.
    Am J Cardiol; 1987 Aug 31; 60(6):3D-9D. PubMed ID: 2888298
    [Abstract] [Full Text] [Related]

  • 17. Modulation of ventricular arrhythmias by catecholamines during evolving infarction in the isolated perfused rat heart.
    Clements-Jewery H, Curtis MJ.
    Proc West Pharmacol Soc; 2001 Aug 31; 44():107-8. PubMed ID: 11793952
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of alpha-adrenergic receptor blockers on the vulnerability of cat heart to ventricular fibrillation.
    Dikshit M, Kar K, Srimal RC.
    Arch Int Pharmacodyn Ther; 1989 Aug 31; 302():119-27. PubMed ID: 2576890
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.